Newron Pharmaceuticals S.p.A.
NWRN | SW
Overview
Corporate Details
- ISIN(s):
- IT0004147952
- LEI:
- 8156002F8C11F80A9740
- Country:
- Italy
- Address:
- VIA MEUCCI, 3, 20091 BRESSO
- Website:
- https://www.newron.com/
- Sector:
- Health Care
- Industry:
- Biotechnology
Description
Newron Pharmaceuticals S.p.A. is a biopharmaceutical company focused on the development of innovative therapies for diseases of the central and peripheral nervous system.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
Market Cap data is planned for a future update.
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-05-12 07:00 |
Regulatory News Service
Newron gibt Genehmigung fur zulassungsrelevantes Phase-III-Entwicklungsprogram…
|
German | 12.6 KB | |
| 2025-05-12 02:00 |
Regulatory News Service
EQS-Adhoc: Newron gibt Genehmigung für zulassungsrelevantes Phase-III-Entwickl…
|
German | 11.3 KB | |
| 2025-05-12 02:00 |
Regulatory News Service
EQS-News: Newron announces approval for pivotal Phase III ENIGMA-TRS program w…
|
English | 19.4 KB | |
| 2025-05-12 02:00 |
Regulatory News Service
EQS-News: Newron gibt Genehmigung für zulassungsrelevantes Phase-III-Entwicklu…
|
German | 22.8 KB | |
| 2025-04-24 16:22 |
Directors' Dealings
Newron Pharmaceuticals S.p.A.: Tuula Martin, buy
|
English | 6.3 KB | |
| 2025-04-23 11:30 |
Regulatory News Service
Generalversammlung 2025 von Newron Pharmaceuticals: Chris Martin zum neuen Verw…
|
German | 7.5 KB | |
| 2025-04-07 17:17 |
Directors' Dealings
Newron Pharmaceuticals S.p.A.: Stefan Weber, buy
|
English | 5.9 KB | |
| 2025-04-01 07:00 |
Regulatory News Service
Newron gibt Geschaftsergebnisse 2024 und Ausblick 2025 bekannt
|
German | 12.5 KB | |
| 2025-03-24 17:45 |
Regulatory News Service
Newron schlagt renommierten Biopharma-Firmengrunder und -Unternehmer Dr. Chris …
|
German | 8.9 KB | |
| 2025-01-09 07:00 |
Regulatory News Service
Newron and Myung In Pharm announce license agreement for evenamide in South Kor…
|
English | 20.8 KB | |
| 2025-01-09 01:00 |
Regulatory News Service
EQS-News: Newron and Myung In Pharm announce license agreement for evenamide in…
|
English | 16.9 KB | |
| 2025-01-09 01:00 |
Regulatory News Service
EQS-News: Newron und Myung In Pharm geben Lizenzvereinbarung für Evenamide in S…
|
German | 19.1 KB | |
| 2024-12-13 01:00 |
Regulatory News Service
EQS-Adhoc: Newron und EA Pharma (Tochtergesellschaft von Eisai Co., Ltd.) geben…
|
German | 16.2 KB | |
| 2024-12-13 01:00 |
Regulatory News Service
EQS-News: Newron and EA Pharma (a subsidiary of Eisai Co., Ltd.) announce licen…
|
English | 19.1 KB | |
| 2024-12-13 01:00 |
Regulatory News Service
EQS-News: Newron und EA Pharma (Tochtergesellschaft von Eisai Co., Ltd.) geben …
|
German | 22.0 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
Vivoryon Therapeutics N.V. | Germany | VVY | |
|
Vytrus Biotech S.A. | Spain | VYT | |
|
WntResearch AB | Sweden | WNT | |
|
Xbrane Biopharma | Sweden | XBRANE | |
|
Xintela AB | Sweden | XINT | |
|
XTL Biopharmaceuticals Ltd. | Israel | XTLB | |
|
Zealand Pharma | Denmark | ZEAL | |
|
Zelluna ASA | Norway | ULTI | |
|
Zephyrus Wing Energies Ltd. | Israel | ZPRS | |
|
Ziccum AB | Sweden | ZICC |